Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

被引:130
作者
Fox, HC
McLean, A
Turner, JJD
Parrott, AC
Rogers, R
Sahakian, BJ
机构
[1] Univ E London, Dept Psychol, London E15 4LZ, England
[2] Univ Cambridge, Addenbrookes Hosp, Sch Med, Dept Psychiat, Cambridge CB2 2QQ, England
[3] Univ Oxford, Dept Psychiat, Oxford OX1 2JD, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
ecstasy; memory; learning; temporal; neurotoxicity; serotonin;
D O I
10.1007/s00213-002-1071-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Experimental evidence has shown that 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") can act as a serotonergic neurotoxin in laboratory animals. The serotonin system predominantly innervates frontal and limbic regions of the brain and has been associated with consolidatory learning and mnemonic processes in humans. Objectives: The aim of the present study was to investigate the cognitive neuropsychological profile of drug-free ecstasy users by employing a selection of tasks previously associated with lesion or neuro-degenerative damage to the temporal lobe or fronto-striatal regions. Methods: The study comprised 40 participants: 20 ecstasy polydrug users and 20 polydrug users who had never taken ecstasy. Results: Ecstasy users were significantly impaired on a recognition task for complex visual patterns and spatial working memory, as a function of task difficulty rather than systematic search strategy. They also showed a trend towards impairment on several learning paradigms. Ecstasy users remained relatively unimpaired on most measures associated with prefrontal functioning, with the exception of verbal fluency "letter" generation. Conclusions: Initial cognitive deficits in ecstasy polydrug users may be more apparent in tasks known to be sensitive to temporal functioning.
引用
收藏
页码:203 / 214
页数:12
相关论文
共 64 条
[1]  
Aguirre N, 1997, J NEUROCHEM, V68, P1099
[2]   Effect of central 5-hydroxytryptamine depletion on performance in the ''time left'' procedure: further evidence for a role of the 5-hydroxytryptaminergic pathways in behavioural ''switching'' [J].
AlRuwaitea, ASA ;
AlZahrani, SSA ;
Ho, MY ;
Bradshaw, CM ;
Szabadi, E .
PSYCHOPHARMACOLOGY, 1997, 134 (02) :179-186
[3]   DIFFERENTIAL BEHAVIORAL EFFECTS IN FRONTAL LOBE DISEASE [J].
BENTON, AL .
NEUROPSYCHOLOGIA, 1968, 6 (01) :53-&
[4]   Memory impairment in abstinent MDMA ("Ecstasy") users [J].
Bolla, KI ;
McCann, UD ;
Ricaurte, GA .
NEUROLOGY, 1998, 51 (06) :1532-1537
[5]   EFFECT OF ACUTE MONOAMINE DEPLETION ON 3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED NEUROTOXICITY [J].
BRODKIN, J ;
MALYALA, A ;
NASH, JF .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (03) :647-653
[6]   Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes [J].
Cavedini, P ;
Riboldi, G ;
D'Annucci, A ;
Belotti, P ;
Cisima, M ;
Bellodi, L .
NEUROPSYCHOLOGIA, 2002, 40 (02) :205-211
[7]  
COHEN JD, 1998, PREFRONTAL CORTEX EX, P195
[8]   Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence [J].
Dafters, RI ;
Duffy, F ;
O'Donnell, PJ ;
Bouquet, C .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :82-90
[9]  
DESOUZA EB, 1990, ANN NY ACAD SCI, V600, P682
[10]   IMPAIRED EXTRA-DIMENSIONAL SHIFT PERFORMANCE IN MEDICATED AND UNMEDICATED PARKINSONS-DISEASE - EVIDENCE FOR A SPECIFIC ATTENTIONAL DYSFUNCTION [J].
DOWNES, JJ ;
ROBERTS, AC ;
SAHAKIAN, BJ ;
EVENDEN, JL ;
MORRIS, RG ;
ROBBINS, TW .
NEUROPSYCHOLOGIA, 1989, 27 (11-12) :1329-1343